Shareholding disclosure

Investor AB

Declared position

12.47%

Threshold

Crossed upwards

Timeline

Published

23.01.2016

Transaction

21.01.2016

Voting rights breakdown

Voting rights acquired12.47%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAG1M000D0

Beneficial owner

Investor AB

Declared address

Investor AB, 103 32 Stockholm

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Investor AB

Newron Pharmaceuticals S.p.A.23.01.2016TAG1M000D0

Disclosure summary

Investor AB disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 23.01.2016, at 12.47% of voting rights. Notice category: Single shareholder.

Disclosed position

12.47%

Voting rights acquired

Voting rights acquired12.47%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Investor AB disclosed a holding in Newron Pharmaceuticals S.p.A., published on 23.01.2016.

Publication date23.01.2016

Transaction date21.01.2016

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerInvestor AB

Declared addressInvestor AB, 103 32 Stockholm

CategorySingle shareholder

Voting rights acquired12.47%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAG1M000D0

Source: SIX Exchange Regulation · Publication date: 23.01.2016

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open